SIGN cutaneous melanoma guideline


Easy-to-read summary of SIGN’s guideline on the management of cutaneous melanoma in primary care.

Melanoma skin cancer incidence rates in the UK have increased by 360% since the late 1970s. Cutaneous melanoma carries a significant risk of metastasis if left to develop into advanced melanoma and is a major cause of skin cancer mortality. However, patients can be encouraged to avoid exposure to factors that increase their risk of developing melanoma and it can often be treated by surgery if recognised at an early stage.

This new Guidelines summary covers the prevention and diagnosis of cutaneous melanoma, as well as how to support patients in primary care.

Register or subscribe to view this content

Please sign in to continue reading this content, or …

Register for FREE

Guidelines for Nurses is free for UK-based doctors, nurses, and pharmacists.

Sign-up now—it takes just a few minutes and you’ll get unlimited access to all of our content, including summaries, expert articles, tools and resources, and CPD modules.

Or read for £5

Pay £5.00 to continue reading this content.

This will entitle you to unlimited access to our summaries, expert articles, and CPD modules for 30 days.